A New Era for EU Pharma
The EU has adopted its most significant reform of pharmaceutical legislation in over twenty years.
Colette is a Partner in our Litigation & Investigations department, specialising in Intellectual Property and a member of our Life Sciences, MedTech & Healthcare and Food, Beverage & Agribusiness sectors.
Colette is a seasoned commercial litigator with extensive experience acting for the world’s leading pharmaceutical, biotechnology and technology companies and retail brands in complex intellectual property disputes before the Irish Commercial Court. Her practice encompasses high-stakes patent litigation, trade mark enforcement, copyright infringement, regulatory disputes, portfolio management, brand protection strategies and the IP aspects of corporate transactions.
Colette is the Irish representative on the Marques Copyright Team ECTA Copyright Committee and the ECTA Copyright Committee. She has been a lecturer in IP for over 12 years for the Law Society of Ireland on the Law Society’s Diploma, Certificate and Graduate Programmes and co-authored the Law Society of Ireland’s Intellectual Property chapter. Colette is also a registered Irish and European Trade Mark and Design Attorney.
Colette is ranked as a “Leading Partner” in Intellectual Property in Legal 500 EMEA 2026, in Chambers Europe 2026, as a “patent expert” (silver) in 2026 IAM Patent 1000 and a “patent star” in Managing IP’s IP Stars 2025.
Recent significant cases include representing/advising:
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
The EU has adopted its most significant reform of pharmaceutical legislation in over twenty years.
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Letters Rogatory given full effect despite lack of full and frank disclosure by the plaintiff.
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Saturday 26 April, was World Intellectual Property Day. To celebrate the theme this year, IP and Music: Feel the Beat of IP, we take a look at the ...
Array
(
[0] => WP_Term Object
(
[term_id] => 12944
[name] => Announcement
[slug] => announcement
[term_group] => 0
[term_taxonomy_id] => 12944
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 101
[filter] => raw
[cat_ID] => 12944
[category_count] => 101
[category_description] =>
[cat_name] => Announcement
[category_nicename] => announcement
[category_parent] => 0
)
[1] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
[2] => WP_Term Object
(
[term_id] => 36
[name] => Awards
[slug] => awards
[term_group] => 0
[term_taxonomy_id] => 36
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 60
[filter] => raw
[cat_ID] => 36
[category_count] => 60
[category_description] =>
[cat_name] => Awards
[category_nicename] => awards
[category_parent] => 0
)
[3] => WP_Term Object
(
[term_id] => 33
[name] => Press Release
[slug] => press-release
[term_group] => 0
[term_taxonomy_id] => 33
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 33
[filter] => raw
[cat_ID] => 33
[category_count] => 33
[category_description] =>
[cat_name] => Press Release
[category_nicename] => press-release
[category_parent] => 0
)
)
William Fry is proud to announce that the Firm has won two awards at the Managing IP Awards 2025 having won 'Irish Trademark Disputes Firm of the Y...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
Critical Medicines Act - the European Commission's new strategy for preventing drug shortages.
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
On 11 February 2025, the European Commission withdrew proposals for regulating Standard Essential Patents.
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
In a sweet victory for Thatchers, the Court of Appeal of England & Wales overturned the IPEC's controversial 2024 ruling and found that Aldi took u...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
[1] => WP_Term Object
(
[term_id] => 1
[name] => Events
[slug] => events
[term_group] => 0
[term_taxonomy_id] => 1
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 61
[filter] => raw
[cat_ID] => 1
[category_count] => 61
[category_description] =>
[cat_name] => Events
[category_nicename] => events
[category_parent] => 0
)
)
William Fry's AI Summit saw AI, data, law and policy experts discuss the opportunities and challenges with AI and what to expect in the future.
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
The Supreme Court has refused leave to Teva to appeal a preliminary injunction granted to Bristol-Myers Squibb pending the outcome of ongoing revoc...
Array
(
[0] => WP_Term Object
(
[term_id] => 49
[name] => Article and Insights
[slug] => articlesinsights
[term_group] => 0
[term_taxonomy_id] => 49
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 5525
[filter] => raw
[cat_ID] => 49
[category_count] => 5525
[category_description] =>
[cat_name] => Article and Insights
[category_nicename] => articlesinsights
[category_parent] => 0
)
)
As the UPC opens its doors, we bring you the latest news as to when a referendum ratifying the UPC Agreement can be expected.